209
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Effects of comorbid anxiety disorders on the course of bipolar disorder-I

&
Pages 552-556 | Accepted 30 Jan 2015, Published online: 13 Mar 2015

References

  • Feinstein AR. Pre-therapeutic classification of comorbidity in chronic disease. J Chron Dis 1970;23:455–68.
  • Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry 1999;40:57–87.
  • Brieger P, Rottig S, Rottig D, Marneros A, Priebe S. Dimensions underlying outcome criteria in bipolar I disorder. J Affect Disord 2007;99:1–7.
  • Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64:543–52.
  • Vázquez GH, Baldessarini RJ, Tondo L. Co-occurrence of anxiety and bipolar disorders: Clinical and therapeutic overview. Depress Anxiety 2014;31:196–206.
  • Tamam L, Ozpoyraz N. Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Psychopathology 2002;35:203–39.
  • Maj M. “Psychiatric comorbidity”: An artifact of current diagnostic systems? Br J Psychiatry 2005;186:182–4.
  • Fortin M, Soubhi H, Hudon C, Bayliss EA, van den Akker M. Multimorbidity's many challenges. BMJ 2007;334:1016–7.
  • Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: Implications for understanding health and health services. Ann Fam Med 2009;7:357–63.
  • van Praag HM. Comorbidity (psycho)analysed. Br J Psychiatry 1996;168:129–34.
  • Wittchen HU. Critical issues in the evaluation of comorbidity of psychiatric disorders. Br J Psychiatry 1996;168:9–16.
  • van Praag HM. Impact psychopharmacology and biological psychiatry. Dialog Clin Neurosci 1999;1:141–51.
  • Zimmerman M, Mattia JI. Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Compr Psychiatry 1999;40:182–91.
  • Schaffer A, McIntosh D, Goldstein BI, Rector NA, McIntyre RS, Beaulieu S, et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry 2012;24:6–22.
  • Deckersbach T, Peters AT, Sylvia L, Urdahl A, Magalhães PV, Otto MW, et al. Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. Am J Psychiatry 2014;171:178–86.
  • Young LT, Cooke RG, Robb JC, Levitt AJ, Joffe RT. Anxious and non-anxious bipolar disorder. J Affect Disord 1993;29:49–52.
  • Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder patients: Data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004;161:2222–9.
  • Vieta E, Colom F, Corbella B, Martinez-Aran A, Reinares M, Benabarre A, et al. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord 2001;3:253–8.
  • Sala R, Goldstein B, Morcillo C, Liu SM, Castellanos M, Blanco C. Course of comorbid anxiety disorders among adults with bipolar disorder in the US population. J Psychiatr Res 2012;46:865–72.
  • Hawke LD, Provencher MD, Parikh SV, Zagorski B. Comorbid anxiety disorders in Canadians with bipolar disorder: Clinical characteristics and service use. Can J Psychiatry 2013;58:393–401.
  • Provencher MD, Guimond AJ, Hawke LD. Comorbid anxiety in bipolar spectrum disorders: A neglected research and treatment issue? J Affect Disord 2012;137:161–4.
  • Ozerdem A, Yazıcı O, Oral ET, Tunca Z, Vahip S, Kurt E, and the Mood Disorders Study Group Psychiatric Association of Turkey. Establishment of a registry program for bipolar illness in Turkey. International Society of Affective Disorders 2nd Biennial Conference-Cancun, Mexico. J Affect Disord 2004;78:86.
  • Tırpan K, Ozerdem A, Tunca Z, Yazıcı O, Oral ET, Kurt E, et al. A computerized registry program for bipolar illness in Turkey. J Affect Disord 2004;78:142.
  • American Psychiatric Association. Diagnostic and statistical manual for mental disorders, 4th edition. Washington DC: PA; 1994.
  • First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders clinical version. Washington, DC: American Psychiatric Press; 1997.
  • Corapcioglu A, Aydemir O, Yildiz M, Esen A, Koroglu E. DSM-IV eksen 1 ruhsal bozukluklarına göre Türkçe yapılandırılmıs klinik deg erlendirmenin güvenirliği. İlaç ve Tedavi Dergisi 1999;12:33–6.
  • Baek JH, Cha B, Moon E, Ha TH, Chang JS, Kim JH, et al. The effects of ethnic, social and cultural factors on axis I comorbidity of bipolar disorder: Results from the clinical setting in Korea. J Affect Disord 2014;166:264–9.
  • Ibiloğlu AO, Caykoylu A. The comorbidity of anxiety disorders in bipolar I and bipolar II patients among Turkish population. J Anxiety Disord 2011;25:661–7.
  • Kawa I, Carter JD, Joyce PR, Doughty CJ, Frampton CM, Wells JE, et al. Gender differences in bipolar disorder: Age of onset, course, comorbidity, and symptom presentation. Bipolar Disord 2005;7:119–25.
  • Latalova K, Prasko J, Grambal A, Havlikova P, Jelenova D, Mainerova B, et al. Bipolar disorder and anxiety disorders. Neuro Endocrinol Lett 2013;34(8):738–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.